Who Owns Adial Pharmaceuticals Stock?
NASDAQ: ADILHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 29.85%
- Held by insiders
- 7.08%
- Institutional holders
- 19
- Institutions 29.9%
- Insiders 7.1%
- Public and other 63.1%
Who owns Adial Pharmaceuticals stock?
Institutional investors own about 29.9% of Adial Pharmaceuticals's shares, spread across 19 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 7.08% of ADIL.
The largest institutional holders are Jane Street Group, LLC (1.22%), Citadel Advisors Llc (1.13%) and Stonex Group Inc. (0.75%). Together, the top 10 institutions control 5.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ADIL positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADIL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jane Street Group, LLC | 32.12K | 1.22% | +100.0% |
| Citadel Advisors Llc | 29.55K | 1.13% | +100.0% |
| Stonex Group Inc. | 19.70K | 0.75% | +100.0% |
| UBS Group AG | 19.15K | 0.73% | +3432.7% |
| Geode Capital Management, LLC | 12.39K | 0.47% | -48.9% |
| China Universal Asset Management Co., Ltd. | 8.00K | 0.30% | +100.0% |
| Vanguard Fiduciary Trust Co | 5.88K | 0.22% | 0.0% |
| Vanguard Capital Management LLC | 5.83K | 0.22% | +1515.2% |
| Manchester Capital Management, LLC | 1.92K | 0.07% | 0.0% |
| Tower Research Capital LLC (TRC) | 1.42K | 0.05% | +4.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ADIL
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 11.83K | 0.45% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 361 | 0.01% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 310 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Adial Pharmaceuticals?
Jane Street Group, LLC is the largest institutional shareholder of ADIL, owning 1.22% of shares outstanding (32.12K shares) as of its latest 13F filing.
What percentage of Adial Pharmaceuticals is owned by institutions?
Institutions own about 29.9% of ADIL shares and 32.1% of the public float.
How much of Adial Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 7.08% of ADIL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.